Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low-dose LPS alleviates early brain injury after SAH by modulating microglial M1/M2 polarization via USP19/FOXO1/IL-10/IL-10R1 signaling. | Redox Biol | 2023 | 37672892 | PubTator, text mining | PubMed |
| Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia. | JCI Insight | 2023 | 37672481 | PubTator, text mining | PubMed |
| circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. | J Cancer | 2023 | 37670963 | PubTator, text mining | PubMed |
| Cardiac-to-adipose axis in metabolic homeostasis and diseases: special instructions from the heart. | Cell Biosci | 2023 | 37667400 | PubTator, text mining | PubMed |
| FBXW7 in breast cancer: mechanism of action and therapeutic potential. | J Exp Clin Cancer Res | 2023 | 37658431 | PubTator, text mining | PubMed |
| Single-cell analysis of human prepuce reveals dynamic changes in gene regulation and cellular communications. | BMC Genomics | 2023 | 37658288 | PubTator, text mining | PubMed |
| Computational immunohistochemical mapping adds immune context to histological phenotypes in mouse models of colitis. | Sci Rep | 2023 | 37658187 | PubTator, text mining | PubMed |
| Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. | Medicina (Kaunas) | 2023 | 37629751 | PubTator, text mining | PubMed |
| Unraveling the Molecular Puzzle: Exploring Gene Networks across Diverse EMT Status of Cell Lines. | Int J Mol Sci | 2023 | 37628965 | PubTator, text mining | PubMed |
| Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. | Cancers (Basel) | 2023 | 37627209 | PubTator, text mining | PubMed |
| EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. | Cell Death Dis | 2023 | 37626035 | PubTator, text mining | PubMed |
| Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database. | Cancer Med | 2023 | 37605516 | PubTator, text mining | PubMed |
| KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer. | Exp Ther Med | 2023 | 37602310 | PubTator, text mining | PubMed |
| Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy. | Front Endocrinol (Lausanne) | 2023 | 37600716 | PubTator, text mining | PubMed |
| Endometrial proteomic profile of patients with repeated implantation failure. | Front Endocrinol (Lausanne) | 2023 | 37583433 | PubTator, text mining | PubMed |
| High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA. | Signal Transduct Target Ther | 2023 | 37574469 | PubTator, text mining | PubMed |
| Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma. | Cell Death Dis | 2023 | 37573347 | PubTator, text mining | PubMed |
| Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma. | Comput Struct Biotechnol J | 2023 | 37564101 | PubTator, text mining | PubMed |
| HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2. | Theranostics | 2023 | 37554278 | PubTator, text mining | PubMed |
| [Inhibitory Effect of Resveratrol on the Proliferation of Multiple Myeloma Cells and the Underlying Mechanism]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2023 | 37551482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=22